Veritas In Silico (TSE:130A) Additional Paid-In Capital : 円2,335.8 Mil(As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Veritas In Silico Additional Paid-In Capital?

Veritas In Silico's quarterly additional paid-in capital increased from Mar. 2024 (円1,887.8 Mil) to Jun. 2024 (円2,335.8 Mil) but then stayed the same from Jun. 2024 (円2,335.8 Mil) to Dec. 2024 (円2,335.8 Mil).

Veritas In Silico's annual additional paid-in capital declined from Dec. 2022 (円1,594.0 Mil) to Dec. 2023 (円1,452.6 Mil) but then increased from Dec. 2023 (円1,452.6 Mil) to Dec. 2024 (円2,335.8 Mil).

Veritas In Silico Additional Paid-In Capital Historical Data

The historical data trend for Veritas In Silico's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veritas In Silico Additional Paid-In Capital Chart

Veritas In Silico Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

1,424.20

1,593.97

1,452.59

2,335.77

Veritas In Silico Quarterly Data
	Dec21	Dec22	Sep23	Dec23	Mar24	Jun24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial			1,452.59	1,452.59	1,887.77	2,335.77	2,335.77

Veritas In Silico Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Veritas In Silico Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Veritas In Silico's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Veritas In Silico Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veritas In Silico Inc (TSE:130A) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031

Website

https://www.veritasinsilico.com

Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.

Veritas In Silico Headlines

No Headlines